I do think this requires more explanation from CSL. They bought Ruide because plasma derived therapies (apart from Albumin) can’t be imported into China. China plasma derived market was meant to be fast growing. You’d think this is CSL’s core business. The asx release explanation for this sale tells us nothing.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.01 |
Change
1.055(0.40%) |
Mkt cap ! $128.6B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $131.8M | 500.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32 | $265.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.02 | 77 | 11 |
View Market Depth
| Last trade - 15.18pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |